Skip to main content
. 2020 Feb 17;37(4):1279–1301. doi: 10.1007/s12325-020-01251-y

Fig. 6.

Fig. 6

Changes in liver enzymes, liver-related symptoms and quality of life in patients with non-alcoholic liver disease receiving silymarin for 4 months [92]. a Liver function parameters (all comparisons P < 0.001 baseline vs. 4 months); b signs and symptoms of liver disease; c: quality of life. ALT alanine aminotransferase, AP alkaline phosphatase, AST aspartate aminotransferase, GGT gamma-glutamyl transferase, TBIL total bilirubin.

Reproduced with permission from Gillessen et al. [92]